Brand dynamics

Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Company News

Brand dynamics

Group News: HealthGen and Lizhu Group once again top industry rankings, achieving new heights of innovation.

Published Time：

2018-12-18

Guided by China Pharmaceutical University, Chongqing Municipal Commission of Economy and Information Technology, and China Chemical Pharmaceutical Industry Association, and jointly organized by Pharma智网 and China Pharmacy Magazine The 3rd China Pharmaceutical R&D Innovation Summit and the Release of the 2018 Top 100 Chinese Pharmaceutical R&D Strength List was grandly held at the Chongqing Marriott Hotel from June 29 to June 30, 2018. The meeting specially released the "2018 China Pharmaceutical R&D Strength Ranking" (including the general list, chemical drug list, traditional Chinese medicine list, and biological drug list), and awarded prizes to the listed companies.

   

Joincare Pharmaceutical Group Industry Co., Ltd. and its subsidiary, Lizhu Pharmaceutical Group Co., Ltd. With its unique advantages accumulated in multiple fields such as biological drugs, prescription drug preparations, raw materials, health products, OTC, diagnostic reagents and equipment, it has successfully entered the "2018 China Pharmaceutical R&D Comprehensive Strength Ranking" and sub-lists "2018 China Chemical Drug R&D Strength Ranking TOP 100" and "2018 China Biological Drug R&D Strength Ranking", writing a new chapter in the industry status of Jiankangyuan Group with its outstanding scientific research strength.

 

Looking back at the industry influence of Jiankangyuan and Lizhu Group, In the "2018 China Pharmaceutical R&D Comprehensive Strength Ranking", the two companies ranked 13th and 26th respectively. In the "2018 China Chemical Drug R&D Strength Ranking TOP 100", Jiankangyuan and Lizhu Group ranked 12th and 75th respectively; Lizhu Group, with its rapid progress in recent years, has rushed into the top ten of the "2018 China Biological Drug R&D Strength Ranking", ranking 9th.

Previous Page

Mr. Zhu Baoguo and Health Yuan respectively won the China Annual Economic Person Award and the China Poverty Alleviation Contribution Award

Lizhu Monoclonal Antibody receives a $148 million increase in funding, accelerating the development of antibody drugs.

Next Page

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86%EF%BC%8C%E9%A1%B6%E5%B0%96%EF%BC%8C%E9%A6%96%E4%B8%AA%EF%BC%8C%E9%BE%99%E5%A4%B4%EF%BC%8C%E7%9F%A5%E5%90%8D

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home